SAM
AVNS

S.A. Mason’s Avanos Medical AVNS Stock Holding History

S.A. Mason’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,565
Closed -$202K – 319
2021
Q2 		$202K Sell
5,565
-100
-2% -$4.13K 0.14% 156
2021
Q1 		$248K Sell
5,665
-862
-13% -$40.5K 0.19% 139
2020
Q4 		$299K Sell
6,527
-300
-4% -$12.5K 0.25% 106
2020
Q3 		$227K Hold
6,827
– – 0.22% 117
2020
Q2 		$201K Sell
6,827
-1,725
-20% -$49.9K 0.21% 120
2020
Q1 		$230K Sell
8,552
-1,650
-16% -$49.3K 0.28% 96
2019
Q4 		$344K Buy
+10,202
New +$369K 0.33% 91

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

S.A. Mason's AVNS Position: Q3 2021 in Review

S.A. Mason sold out of Avanos Medical (AVNS) in Q3 2021, closing a stake of 5,565 shares — an estimated $202K sold.

S.A. Mason first reported a position in AVNS in Q4 2019 and held it in 7 quarters. The position peaked at $344K in Q4 2019. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2021.

  • S.A. Mason reported no remaining Avanos Medical position as of Q3 2021 after selling out during the quarter.
  • S.A. Mason sold 5,565 Avanos Medical shares in Q3 2021, an estimated $202K.
  • S.A. Mason first reported a position in Avanos Medical in Q4 2019 and held it in 7 quarters.
  • S.A. Mason's Avanos Medical position peaked at $344K in Q4 2019.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2021.

Based on S.A. Mason's 13F filing for Q3 2021, filed 12 Oct 2021.